Premier League
Home › Predictions › Sabah FA vs Slavia Praha
UEFA Champions League · 13 October 2026 · 17:45

Sabah FA vs Slavia Praha – 13 October 2026, UEFA Champions League: H2H, form and match facts

2–0
OddsRecent matchesAnalysisFAQ

Sabah FA vs Slavia Praha (UEFA Champions League) was played on 13 October 2026 and finished 2–0.

Sabah FA vs Slavia Praha: odds from several bookmakers

Match result1X2
Top odds available4.023.981.95
Market average3.823.811.92

Recent matches

Sabah FA

5 AugLAarhus 2–1 Sabah FA
11 AugWSabah FA 4–0 Aarhus
19 AugLHapoel Beer Sheva 2–1 Sabah FA
25 AugWSabah FA 5–2 Hapoel Beer Sheva
10 SeptLManchester United 4–0 Sabah FA

Slavia Praha

5 SeptWSlavia Praha 4–0 Zbrojovka Brno
10 SeptLSlavia Praha 2–3 Lens
13 SeptWTeplice 0–2 Slavia Praha
20 SeptWSlavia Praha 2–1 Plzeň
9 OctWZlín 0–1 Slavia Praha

Sabah FA vs Slavia Praha: our match analysis

Sabah FA will host Slavia Praha in what promises to be a stern test for the home side, who have yet to reveal their recent form. Slavia arrive as league leaders, perched on 20 points after six wins and two draws, boasting an impressive 23‑5 goal difference and remaining unbeaten all season. The Czech champions will look to extend their flawless record, while Sabah hope to capitalize on familiar surroundings to narrow the gap. With the table at stake, the encounter could prove pivotal for both teams’ ambitions.

Sabah FA vs Slavia Praha: common questions

How did Sabah FA vs Slavia Praha end?

Sabah FA beat Slavia Praha 2–0.

When and where was the match played?

13 October 2026, 17:45, at Baku Olympic Stadium. Referee: Sebastian Gishamer.

More matches: UEFA Champions League

Lens vs Sporting CP 13 OctRB Leipzig vs PSV Eindhoven 13 OctAtlético Madrid vs Manchester United 13 OctVillarreal vs Napoli 13 OctViking vs Bayern München 13 OctGalatasaray vs Barcelona 13 OctArsenal vs Lille 13 OctInter vs Club Brugge KV 13 Oct

18+ · Betting is never risk-free. We share our predictions to inform you, and they cannot promise that a bet will win. Gamble with care.